Isao Yoshida

Matsuyama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Gradient of CD79B expression in diffuse large B-cell lymphoma corresponds to stages of germinal center B-cell differentiation.

Gradient of CD79B expression in diffuse large B-cell lymphoma corresponds to stages of germinal center B-cell differentiation.

Journal: Haematologica

Published: November 18, 2025

Trends in net survival for 1,834,894 patients with cancer from 16 population-based cancer registries in Japan, 2000-14 (CONCORD-3).

Trends in net survival for 1,834,894 patients with cancer from 16 population-based cancer registries in Japan, 2000-14 (CONCORD-3).

Journal: Japanese journal of clinical oncology

Published: October 17, 2025

Trends in survival for patients with esophageal cancer in Japan, 2000-14 (CONCORD-3).

Trends in survival for patients with esophageal cancer in Japan, 2000-14 (CONCORD-3).

Journal: Japanese journal of clinical oncology

Published: September 09, 2025

Efficacy and relapse profiles of Pola-R-CHP versus R-CHOP in previously untreated diffuse large B-cell lymphoma: A multicentre real-world study.

Efficacy and relapse profiles of Pola-R-CHP versus R-CHOP in previously untreated diffuse large B-cell lymphoma: A multicentre real-world study.

Journal: British journal of haematology

Published: August 29, 2025

A phase 2 study of ibrutinib with venetoclax in Japanese patients with untreated CLL and SLL.

A phase 2 study of ibrutinib with venetoclax in Japanese patients with untreated CLL and SLL.

Journal: International journal of hematology

Published: August 20, 2025

Trends in 5-year net survival for women diagnosed with breast, cervical or ovarian cancer in Japan, 2000-14 (CONCORD-3).

Trends in 5-year net survival for women diagnosed with breast, cervical or ovarian cancer in Japan, 2000-14 (CONCORD-3).

Journal: Japanese journal of clinical oncology

Published: June 17, 2025

Trends in net survival for patients with brain tumors in Japan, 2000-14 (CONCORD-3).

Trends in net survival for patients with brain tumors in Japan, 2000-14 (CONCORD-3).

Journal: Japanese journal of clinical oncology

Published: June 05, 2025

Comparison of Survival Outcomes Between Chimeric Antigen Receptor T-Cell Therapy Recipients With and Without Central Nervous System Involvement.

Comparison of Survival Outcomes Between Chimeric Antigen Receptor T-Cell Therapy Recipients With and Without Central Nervous System Involvement.

Journal: Clinical lymphoma, myeloma & leukemia

Published: May 30, 2025

Final results of JCOG0601 randomized trial of R-CHOP versus CHOP combined with dose-dense rituximab for diffuse large B-cell lymphoma.

Final results of JCOG0601 randomized trial of R-CHOP versus CHOP combined with dose-dense rituximab for diffuse large B-cell lymphoma.

Journal: Japanese journal of clinical oncology

Published: May 07, 2025

Trends in survival for adult patients with hematopoietic malignancies in Japan, 2000-14 (CONCORD-3).

Trends in survival for adult patients with hematopoietic malignancies in Japan, 2000-14 (CONCORD-3).

Journal: Japanese journal of clinical oncology

Published: April 03, 2025

Trends in survival for children with brain tumors, acute lymphoblastic leukemia, and lymphomas in Japan, 2000-14 (CONCORD-3).

Trends in survival for children with brain tumors, acute lymphoblastic leukemia, and lymphomas in Japan, 2000-14 (CONCORD-3).

Journal: Japanese journal of clinical oncology

Published: March 14, 2025

Trends in survival for patients with lung cancer in Japan, 2000-14 (CONCORD-3).

Trends in survival for patients with lung cancer in Japan, 2000-14 (CONCORD-3).

Journal: Japanese journal of clinical oncology

Published: February 18, 2025

Showing 1-12 of 57

Last Updated: 09/26/2026